黄酮类化合物合成生物学研究进展  

Advances of synthetic biology of flavonoids

作　　者：林春草 陈大伟 戴均贵 LIN Chun-cao;CHEN Da-wei;DAI Jun-gui(State Key Laboratory of Bioactive Substance and Function of Natural Medicines,CAMS Key Laboratory of Enzymes and Natural Drug Biocatalysis,NHC Key Laboratory of Natural Drug Biosynthesis,Institute of Materia Medica,Peking Union Medical College&Chinese Academy of Medical Sciences,Beijing 100050,China)

机构地区：[1]中国医学科学院、北京协和医学院药物研究所,天然药物活性物质与功能国家重点实验室,中国医学科学院酶与天然药物生物催化重点实验室,国家卫生健康委员会天然药物生物合成重点实验室,北京100050

出　　处：《药学学报》2022年第5期1322-1335,共14页Acta Pharmaceutica Sinica

基　　金：国家重点研发计划资助项目(2020YFA0908000)。

摘　　要：黄酮类化合物是植物中广泛分布的一大类次级代谢产物,已报道的化合物超过10000种,结构多样且部分具有抗癌、抗炎等重要的药理活性。黄酮类化合物生物合成相关的基因及酶、生物合成途径解析已有诸多报道;近年来,其合成生物学研究亦取得了较大进展。本文在概述黄酮类化合物生物合成的基础上,对近20年(2001~2021年)报道的黄酮类化合物合成生物学研究进展进行了综述,介绍了代表性黄酮类化合物的细胞工厂创建概况,并对相应的代谢瓶颈及优化策略进行了讨论和展望。Flavonoids is one of the biggest families of the plant-derived secondary metabolites with structural diversity.Until now,over 10000 kinds of flavonoids with distinct structures have been purified and identified from plants,and some of them possess a range of important pharmacological effects,such as anticancer,anti-inflammatory and so on.So far,a number of genes and enzymes responsible for the biosynthesis of flavonoids have been reported,especially,a great of progress has been achieved in the synthetic biology of flavonoids in the recent years.Herein,based upon a brief introduction on the biosynthesis of flavonoids,this review summarizes the research advances in synthetic biology of flavonoids in the past two decades(2001-2021),highlighting the cell factories construction of the representative flavonoids.And,a brief discussion and prospects of the relevant metabolic bottlenecks and optimizing strategies are proposed.

关 键 词：黄酮类化合物 合成生物学 生物合成途径 细胞工厂 代谢瓶颈 

分 类 号：R931[医药卫生—生药学]